GSK plc (LON:GSK)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1,931.50
-8.50 (-0.44%)
Jul 31, 2026, 4:54 PM GMT

GSK plc Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,8215,7162,5754,92814,9564,385
Depreciation & Amortization
1,3382,0942,3402,2942,1472,122
Other Amortization
220220211---
Loss (Gain) From Sale of Assets
-40-40-159-12-221-586
Asset Writedown & Restructuring Costs
2,6701,143369360198498
Loss (Gain) From Sale of Investments
-4-4-16-1-128
Loss (Gain) on Equity Investments
4-1352-33
Stock-Based Compensation
374374344307346343
Other Operating Activities
-447141631-257-9,435-804
Change in Accounts Receivable
-613-613298-794-158-780
Change in Inventory
-140-140-294-424-26951
Change in Accounts Payable
131131-179-15494229
Change in Other Net Operating Assets
17-1,280431377-1,425824
Operating Cash Flow
8,3317,7416,5546,7687,4037,952
Operating Cash Flow Growth
7.86%18.11%-3.16%-8.58%-6.90%-5.79%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,433-1,348-1,399-1,314-1,143-950
Sale of Property, Plant & Equipment
48246528146132
Cash Acquisitions
-2,994-1,709-824-1,468-3,187-114
Divestitures
262-27-1849-43-17
Sale (Purchase) of Intangibles
-1,173-1,522-1,452-1,018-919-1,063
Investment in Securities
2831082,2311,78295334
Other Investing Activities
288241168346-3,721-99
Investing Cash Flow
-4,719-4,233-1,229-1,595-8,772-1,777

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1,215266-1,021301
Long-Term Debt Issued
-1,9791,0752231,025-
Total Debt Issued
1,9473,1941,3412232,046301
Short-Term Debt Repaid
--288-892-333--2,304
Long-Term Debt Repaid
--1,641-1,841-2,457-6,870-181
Total Debt Repaid
-1,172-1,929-2,733-2,790-6,870-2,485
Net Debt Issued (Repaid)
7751,265-1,392-2,567-4,824-2,184
Issuance of Common Stock
101520102521
Repurchase of Common Stock
-1,203-1,377----
Common Dividends Paid
-2,666-2,564-2,444-2,247-3,467-3,999
Other Financing Activities
-964-1,024-910-8379,089-1,427
Financing Cash Flow
-4,048-3,685-4,726-5,641823-7,589

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
13-19-54-99152-29
Net Cash Flow
-380-196545-567-394-1,443

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6,8986,3935,1555,4546,2607,002
Free Cash Flow Growth
7.60%24.02%-5.48%-12.88%-10.60%-6.04%
Free Cash Flow Margin
20.77%19.57%16.43%17.98%21.35%28.35%
Free Cash Flow Per Share
1.691.551.251.331.531.73
Levered Free Cash Flow
3,4833,2844,9543,8374,2664,847
Unlevered Free Cash Flow
3,8963,6955,3394,2814,7785,323

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
697679632766848772
Cash Income Tax Paid
1,1341,2021,3071,3281,310972
Change in Working Capital
-605-1,902256-856-1,358324